Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis

Hong Xia, Vidya Bodempudi, Alexey Benyumov, Polla Hergert, Damien Tank, Jeremy Herrera, Jeff Braziunas, Ola Larsson, Matthew Parker, Daniel Rossi, Karen Smith, Mark Peterson, Andrew Limper, Jose Jessurun, John Connett, David Ingbar, Sem Phan, Peter B. Bitterman, Craig A. Henke

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Idiopathic pulmonary fibrosis (IPF) is a progressive disease of the middle aged and elderly with a prevalence of one million persons worldwide. The fibrosis spreads from affected alveoli into contiguous alveoli, creating a reticular network that leads to death by asphyxiation. Lung fibroblasts from patients with IPF have phenotypic hallmarks, distinguishing them from their normal counterparts: pathologically activated Akt signaling axis, increased collagen and α-smooth muscle actin expression, distinct gene expression profile, and ability to form fibrotic lesions in model organisms. Despite the centrality of these fibroblasts in disease pathogenesis, their origin remains uncertain. Here, we report the identification of cells in the lungs of patients with IPF with the properties of mesenchymal progenitors. In contrast to progenitors isolated from nonfibrotic lungs, IPF mesenchymal progenitor cells produce daughter cells manifesting the full spectrum of IPF hallmarks, including the ability to form fibrotic lesions in zebrafish embryos and mouse lungs, and a transcriptional profile reflecting these properties. Morphological analysis of IPF lung tissue revealed that mesenchymal progenitor cells and cells with the characteristics of their progeny comprised the fibrotic reticulum. These data establish that the lungs of patients with IPF contain pathological mesenchymal progenitor cells that are cells of origin for fibrosis-mediating fibroblasts. These fibrogenic mesenchymal progenitors and their progeny represent an unexplored target for novel therapies to interdict fibrosis.

Original languageEnglish (US)
Pages (from-to)1369-1383
Number of pages15
JournalAmerican Journal of Pathology
Issue number5
StatePublished - May 2014

Bibliographical note

Funding Information:
Supported by National Heart, Lung, and Blood Institute grants R01 HL074882 and P01 HL91775 (C.A.H.) and R01 HL089249 (P.B.B.); funds provided by the O’Brien family ; the Swedish Research Council (O.L.); the National Center for Advancing Translational Sciences of the National Institutes of Health award 8UL1TR000114-02 ; and the Flow Cytometry Core Facility of the Masonic Cancer Center , a comprehensive cancer center designated by the National Cancer Institute, supported in part by P30 CA77598 and the University of Minnesota Imaging Center .


Dive into the research topics of 'Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this